Local Institution

Redondo Beach, California 90277

0 studies enrolling now · 4 studies all time

What they study most

Cancer of the Stomach, Gastric Cancer, Gastroesophageal Junction, Hypertension, Leukemia, Stomach Cancer, Type 2 Diabetes

Studies at this site

• An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma — Withdrawn before enrolling
• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy — Stopped early